GEOVAX LABS, INC. Public Float
GEOVAX LABS, INC. (GOVX) had Public Float of $13.72 million as of 2025-06-30, per its 10-K filed 2026-04-15.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-15
- 2025-06-30: Entity Public Float $13.72M.
- 2024-06-30: Entity Public Float $13.19M.
- 2023-06-30: Entity Public Float $14.36M.
- 2022-06-30: Entity Public Float $13.24M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $13.72M 10-K · filed 2026-04-15 |
| 2024-06-30 | $13.19M 10-K · filed 2025-03-27 |
| 2023-06-30 | $14.36M 10-K/A · filed 2024-03-11 |
| 2022-06-30 | $13.24M 10-K/A · filed 2023-04-27 |
| 2021-06-30 | $30.37M 10-K/A · filed 2022-04-27 |
| 2020-06-30 | $7.61M 10-K · filed 2021-03-23 |
| 2019-06-30 | $416.38K 10-K · filed 2020-03-24 |
| 2018-06-30 | $6.53M 10-K · filed 2019-03-26 |
| 2017-06-30 | $2.46M 10-K · filed 2018-03-23 |
| 2016-06-30 | $2.58M 10-K · filed 2017-03-24 |
| 2015-06-30 | $4.39M 10-K · filed 2016-03-16 |
| 2014-06-30 | $4.78M 10-K · filed 2015-03-20 |
| 2013-06-30 | $7.81M 10-K · filed 2014-03-14 |
| 2012-06-30 | $10.18M 10-K · filed 2013-03-18 |
| 2011-06-30 | $8.74M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |